Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Molecular Devices Introduces Microplate Reader and Washer

Published: Monday, April 28, 2014
Last Updated: Monday, April 28, 2014
Bookmark and Share
The inexpensive and versatile EMax® Plus Microplate Reader and MultiWash™+ Microplate Washer are designed for labs just starting up or looking to extend capabilities with affordable, yet reliable instrumentation that utilizes the industry-standard SoftMax® Pro Microplate Data Acquisition and Analysis Software.

MultiWash 235x235px-websitejpg.jpgThe EMax Plus Microplate Reader measures 96-well plates and comes with eight standard filter modes to cover the entire visible range, for applications such as protein quantification, cell viability, cell proliferation and ELISA. The reader includes multiple licenses to the SoftMax® Pro software for endpoint and kinetic analysis of microplate data, eliminating any need to retrain lab members or compromise data analysis routines when switching between inexpensive low-throughput and powerful higher-throughput plate readers. SoftMax Pro reduces setup time for common assays with more than 140 built-in protocols, which are complemented by a large collection of community-shared protocols and tools for FDA 21 CFR Part 11 regulatory compliance.

The small-footprint Multiwash+ Microplate Washer quickly washes with both 96 and 384-well plates, has 20 standard wash protocols, and a simple LCD screen interface to customize speed, volume, soak time, and aspiration settings. The washer is engineered to be simple to maintain and use, including features that reduce clogging and noise. A set of four wash/rinse bottles and one waste bottle are included for out-of-the-box operation.

EMax Plus 235x235px-websitejpg2.jpg

“Affordable, simple microplate readers and washers are indispensible instrumentation for many labs, both large and small. The EMax Plus reader and MultiWash+ washer provide a robust entry-level extension to the SpectraMax® and Maxline microplate reader families. Both instruments are supported by our global support teams, ensuring longevity and value,” says Martin Verhoef, Vice President, Strategy and Marketing at Molecular Devices.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!